![]()
|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Papers In Press, published online ahead of print March 8, 2006
Dept. of Molecular Cell Biology, University of Maastricht, Maastricht 6200 MD
Corresponding Author: M.Mulder{at}MOLCELB.unimaas.nl
Both apolipoprotein E (apoE) and 24(S)-hydroxycholesterol are involved in the pathogenesis of Alzheimer's disease (AD). It has been hypothesized that apoE affects AD development via isoform-specific effects on lipid trafficking between astrocytes and neurons. However, the regulation of the cholesterol supply of neurons via apoE-containing high density lipoproteins (HDL) remains to be clarified. We show, for the first time, that the brain-specific metabolite of cholesterol produced by neurons, i.e. 24(S)-hydroxycholesterol induces apoE transcription, protein synthesis and secretion in a dose- and time-dependent manner in cells of astrocytic but not of neuronal origin. Moreover, 24(S)-hydroxycholesterol primes astrocytoma, but not neuroblastoma cells, to mediate cholesterol efflux to apoE. Similar results were obtained using the synthetic Liver-X-Receptor (LXR) agonist GW683965A, suggesting involvement of an LXR-controlled signalling pathway. A 10- to 20-fold higher basal LXR± and = expression level in astrocytoma compared to neuroblastoma cells may underlie these differential effects. Furthermore, apoE-mediated cholesterol efflux from astrocytoma cells may be controlled by the ATP-binding cassette transporters ABCA1 and ABCG1, since their expression was also upregulated by both compounds. In contrast, ABCG4 seems not to be involved, as its expression was induced only in neuronal cells. The expression of SREBP-2, LDLR, HMGCoA-Reductase and SREBP-1c was transiently upregulated by GW683965A in astrocytes, but down-regulated by 24(S)-hydroxycholesterol, suggesting that cholesterol efflux and synthesis are regulated independently. In conclusion, evidence is provided that 24(S)-hydroxycholesterol induces apoE-mediated efflux of cholesterol in astrocytes via an LXR-controlled pathway, which may be relevant for chronic and acute neurological diseases.
J. Biol. Chem, 10.1074/jbc.M601019200
Submitted on February 2, 2006
Accepted on March 8, 2006
24(S)-Hydroxycholesterol participates in a Liver X Receptor-controlled pathway in astrocytes that regulates Apolipoprotein E-mediated cholesterol efflux
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
J. R. Morales, I. Ballesteros, J. M. Deniz, O. Hurtado, J. Vivancos, F. Nombela, I. Lizasoain, A. Castrillo, and M. A. Moro Activation of Liver X Receptors Promotes Neuroprotection and Reduces Brain Inflammation in Experimental Stroke Circulation, September 30, 2008; 118(14): 1450 - 1459. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Mast, M. A. White, I. Bjorkhem, E. F. Johnson, C. D. Stout, and I. A. Pikuleva Crystal structures of substrate-bound and substrate-free cytochrome P450 46A1, the principal cholesterol hydroxylase in the brain PNAS, July 15, 2008; 105(28): 9546 - 9551. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Lyly, S. K. Marjavaara, A. Kyttala, K. Uusi-Rauva, K. Luiro, O. Kopra, L. O. Martinez, K. Tanhuanpaa, N. Kalkkinen, A. Suomalainen, et al. Deficiency of the INCL protein Ppt1 results in changes in ectopic F1-ATP synthase and altered cholesterol metabolism Hum. Mol. Genet., May 15, 2008; 17(10): 1406 - 1417. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Abildayeva, J. F. P. Berbee, A. Blokland, P. J. Jansen, F. J. Hoek, O. Meijer, D. Lutjohann, T. Gautier, T. Pillot, J. De Vente, et al. Human apolipoprotein C-I expression in mice impairs learning and memory functions J. Lipid Res., April 1, 2008; 49(4): 856 - 869. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Wang, L. Yvan-Charvet, D. Lutjohann, M. Mulder, T. Vanmierlo, T.-W. Kim, and A. R. Tall ATP-binding cassette transporters G1 and G4 mediate cholesterol and desmosterol efflux to HDL and regulate sterol accumulation in the brain FASEB J, April 1, 2008; 22(4): 1073 - 1082. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. T. Tarr and P. A. Edwards ABCG1 and ABCG4 are coexpressed in neurons and astrocytes of the CNS and regulate cholesterol homeostasis through SREBP-2 J. Lipid Res., January 1, 2008; 49(1): 169 - 182. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Guizzetti, J. Chen, J. F. Oram, R. Tsuji, K. Dao, T. Moller, and L. G. Costa Ethanol Induces Cholesterol Efflux and Up-regulates ATP-binding Cassette Cholesterol Transporters in Fetal Astrocytes J. Biol. Chem., June 29, 2007; 282(26): 18740 - 18749. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Zelcer, N. Khanlou, R. Clare, Q. Jiang, E. G. Reed-Geaghan, G. E. Landreth, H. V. Vinters, and P. Tontonoz Attenuation of neuroinflammation and Alzheimer's disease pathology by liver x receptors PNAS, June 19, 2007; 104(25): 10601 - 10606. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Hirsch-Reinshagen, J. Y. Chan, A. Wilkinson, T. Tanaka, J. Fan, G. Ou, L. F. Maia, R. R. Singaraja, M. R. Hayden, and C. L. Wellington Physiologically regulated transgenic ABCA1 does not reduce amyloid burden or amyloid-{beta} peptide levels in vivo J. Lipid Res., April 1, 2007; 48(4): 914 - 923. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. B. Rowe, E. M. Blalock, K.-C. Chen, I. Kadish, D. Wang, J. E. Barrett, O. Thibault, N. M. Porter, G. M. Rose, and P. W. Landfield Hippocampal Expression Analyses Reveal Selective Association of Immediate-Early, Neuroenergetic, and Myelinogenic Pathways with Cognitive Impairment in Aged Rats J. Neurosci., March 21, 2007; 27(12): 3098 - 3110. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. S. Kim, A. S. Rahmanto, A. Kamili, K.-A. Rye, G. J. Guillemin, I. C. Gelissen, W. Jessup, A. F. Hill, and B. Garner Role of ABCG1 and ABCA1 in Regulation of Neuronal Cholesterol Efflux to Apolipoprotein E Discs and Suppression of Amyloid-beta Peptide Generation J. Biol. Chem., February 2, 2007; 282(5): 2851 - 2861. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Vaughan and J. F. Oram ABCA1 and ABCG1 or ABCG4 act sequentially to remove cellular cholesterol and generate cholesterol-rich HDL J. Lipid Res., November 1, 2006; 47(11): 2433 - 2443. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |